These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37714635)

  • 1. How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ.
    Record SM; Hwang ES; Chiba A
    Surg Oncol Clin N Am; 2023 Oct; 32(4):663-673. PubMed ID: 37714635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal Carcinoma In Situ - Quo Vadis?
    Peltecu G
    Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?
    Rosso KJ; Weiss A; Thompson AM
    Surg Oncol Clin N Am; 2018 Jan; 27(1):69-80. PubMed ID: 29132566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Ductal Carcinoma In Situ: Advances and Future Perspectives.
    Behbod F; Chen JH; Thompson A
    Cold Spring Harb Perspect Med; 2023 Oct; 13(10):. PubMed ID: 36781223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
    Mitchell KB; Kuerer H
    Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approach and future perspective for ductal carcinoma in situ of the breast.
    Kanbayashi C; Iwata H
    Jpn J Clin Oncol; 2017 Aug; 47(8):671-677. PubMed ID: 28486668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [For which patients could we consider de-escalation in the management of ductal carcinomas in situ?].
    Azaïs H; Maingon P; Da Maïa E; Nikpayam M; Gonthier C; Belghiti J; Canlorbe G; Uzan C
    Gynecol Obstet Fertil Senol; 2019 Dec; 47(12):872-879. PubMed ID: 31562924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.
    Lazzeroni M; Dunn BK; Pruneri G; Jereczek-Fossa BA; Orecchia R; Bonanni B; DeCensi A
    Cancer Treat Rev; 2017 Apr; 55():1-9. PubMed ID: 28262606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of ductal carcinoma in situ (DCIS).
    Virnig BA; Shamliyan T; Tuttle TM; Kane RL; Wilt TJ
    Evid Rep Technol Assess (Full Rep); 2009 Sep; (185):1-549. PubMed ID: 20629475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.
    Sagara Y; Freedman RA; Wong SM; Aydogan F; Nguyen A; Barry WT; Golshan M
    Breast Cancer Res Treat; 2017 Nov; 166(2):583-592. PubMed ID: 28776282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspectives of treatment of ductal carcinoma in situ.
    Estévez LG; Alvarez I; Seguí MÁ; Muñoz M; Margelí M; Miró C; Rubio C; Lluch A; Tusquets I
    Cancer Treat Rev; 2010 Nov; 36(7):507-17. PubMed ID: 20462701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence map of ductal carcinoma in situ management options.
    Bouskill K; Hempel S; Richardson A; Ganz PA; Baxi S; Zutshi R; Larkin J; Motala A; Miles JNV; Crandall CJ
    Menopause; 2019 Nov; 26(11):1250-1258. PubMed ID: 31567868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current treatment of ductal carcinoma in situ.
    Schwartz GF;
    Breast J; 2001; 7(5):308-10. PubMed ID: 11906440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.